Systane Clinical Experience Study
Phase 4
Completed
- Conditions
- Dry Eye Syndrome
- Interventions
- Other: Systane
- First Posted Date
- 2009-01-08
- Last Posted Date
- 2012-02-02
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 941
- Registration Number
- NCT00818909
Role of Nepafenac in Reducing Macular Volume After Epiretinal Membrane Surgery
- First Posted Date
- 2009-01-08
- Last Posted Date
- 2015-08-14
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 40
- Registration Number
- NCT00818844
- Locations
- 🇺🇸
Dan Miller, Cincinnati, Ohio, United States
Corneal Astigmatism Measurement Study
Completed
- Conditions
- Astigmatism
- First Posted Date
- 2009-01-07
- Last Posted Date
- 2012-04-09
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 50
- Registration Number
- NCT00818532
- Locations
- 🇺🇸
Alcon Call Center for Trial Locations, Fort Worth, Texas, United States
Visual Function Evaluation of Bilateral AcrySof ReSTOR Aspheric IOL
Phase 4
Completed
- Conditions
- Cataracts
- Interventions
- Device: AcrySof ReSTOR Aspheric IOL
- First Posted Date
- 2009-01-07
- Last Posted Date
- 2010-07-30
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 34
- Registration Number
- NCT00818116
- Locations
- 🇺🇸
Alcon Call Center for Trial Locations, Fort Worth, Texas, United States
Kynex Versus Refresh Plus Study in Subject With Dry Eye
Phase 4
Completed
- Conditions
- Dry Eye
- Interventions
- Other: Carboxymethylcellulose sodiumOther: Sodium Hyaluronate
- First Posted Date
- 2008-12-17
- Last Posted Date
- 2012-02-03
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 67
- Registration Number
- NCT00809198
Residence Time Evaluation of Marketed OTC Ophthalmic Products
Not Applicable
Completed
- Conditions
- Dry Eye
- Interventions
- Other: Systane Ultra Lubricant Eye DropsOther: Unisol 4 Saline Solution
- First Posted Date
- 2008-12-09
- Last Posted Date
- 2012-02-02
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 25
- Registration Number
- NCT00804791
Circadian Ocular Perfusion Pressure and Ocular Blood Flow
Phase 4
Completed
- Conditions
- Glaucoma
- Interventions
- First Posted Date
- 2008-12-02
- Last Posted Date
- 2013-03-22
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 35
- Registration Number
- NCT00800540
- Locations
- 🇺🇸
Contact Alcon Call Center at 1-888-451-3937 For Trial Locations, Fort Worth, Texas, United States
Evaluation of Contact Lenses and Conjunctival Staining in Normal Patients
Not Applicable
Completed
- Conditions
- Conjunctival Staining
- Interventions
- Device: ReNu MultiPlusDevice: Complete Easy RubDevice: Clear CareDevice: Contact lenses
- First Posted Date
- 2008-11-27
- Last Posted Date
- 2012-11-16
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 26
- Registration Number
- NCT00799422
- Locations
- 🇺🇸
Alcon Call Center for Trial Locations, Fort Worth, Texas, United States
Examination of Ocular Surface Effects With Administration of Travatan Z and XALATAN
Phase 4
Completed
- Conditions
- Ocular HypertensionOpen-angle Glaucoma
- Interventions
- First Posted Date
- 2008-11-26
- Last Posted Date
- 2012-06-01
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 236
- Registration Number
- NCT00798759
Study of the Progression of Bacterial Conjunctivitis Symptoms Upon Antibiotic Treatment
Phase 4
Completed
- Conditions
- Bacterial Conjunctivitis
- Interventions
- First Posted Date
- 2008-11-26
- Last Posted Date
- 2010-03-31
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 24
- Registration Number
- NCT00798577
- Locations
- 🇺🇸
Contact Alcon Call Center For Trial Locations, Fort Worth, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath